PHARMACOTHERAPEUTIC FOLLOW-UP DIRECTED TO DOMESTIC ANIMALS: WOULD IT BE FEASIBLE?
DOI:
https://doi.org/10.14450/2318-9312.v26.e4.a2014.pp246-250Keywords:
pharmacotherapeutic follow-up, patient safety, domesticated animalAbstract
The overall performance in the area of human health has directed its focus to patient care, taking the medicine as the background. In this sense, the human pharmacotherapeutic follow-up (which is part of the Pharmaceutical Care) has been a great tool to aid the detection of Drug Related Problems (DRP) so they can be avoided or identified in order to prevent / minimize the emergence of Drug Negative Outcomes (DNO). Considering the need of therapeutic success as a result to obtain in health care, a reflection on the possibility of a follow-up model (Dáder modified) to be adapted and applied to the pharmacotherapeutic monitoring animal area, particularly, in domestic animals with chronic use of medications is presented.Downloads
Published
2014-12-18
How to Cite
Nicoletti, M. A., & Fukushima, A. R. (2014). PHARMACOTHERAPEUTIC FOLLOW-UP DIRECTED TO DOMESTIC ANIMALS: WOULD IT BE FEASIBLE?. Infarma - Pharmaceutical Sciences, 26(4), 246–250. https://doi.org/10.14450/2318-9312.v26.e4.a2014.pp246-250
Issue
Section
Technical Note
License
Authors who publish in this journal agree to the following terms:
- Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
- Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
- Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).